Dayyani, F., Zurita, A. J., Nogueras-González, G. M., Slack, R., Millikan, R. E., Araujo, J. C., . . . Corn, P. G. (2016). The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study. BMC Cancer.

Dayyani, Farshid, Amado J. Zurita, Graciela M. Nogueras-González, Rebecca Slack, Randall E. Millikan, John C. Araujo, Gary E. Gallick, Christopher J. Logothetis, and Paul G. Corn. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.

Dayyani, Farshid, et al. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.